Emerging Companies / Venture Capital

The transactional lawyers at Honigman have earned a national reputation for skilled representation of innovators and founders of start-ups and emerging companies and the investors and funds that support, fuel, and accelerate the growth of today’s disruptors.

Honigman is among the leaders in representation of investors and emerging companies throughout the dynamic sectors covering life sciences, biotechnology, medical device, pharmaceuticals, advanced manufacturing, and information technology.

From Silicon Valley (through the Midwest) to New York, Honigman is a go-to law firm to investors and venture capital funds

Honigman knows the venture capital ecosystem. Deeply entrenched from Silicon Valley to New York, we advise VC funds and individual investors in all of their business needs. From fund formation to executive investment strategy, the Honigman venture capital team delivers. Since 2020, we have completed transactions for 100+ investors and VC-backed portfolio companies exceeding $7 billion.

Trusted advisor to the founders, entrepreneurs and disruptors of emerging companies; bringing their innovations to market

No two companies are identical. Honigman’s emerging company team continually – and successfully – guides emerging companies through the start-up phase to build the foundation for a runway of growth. Clients receive exceptional service, competitive cost structures to ensure maximized runway, and market knowledge to foresee issues and opportunities to ensure optimal outcomes.

A comprehensive service offering at the intersection of investment and company operations

The Honigman team offers a market competitive package to investors to form its investment vehicles, execute its investment strategy, and manage the day-to-day operations of that investment with an eye on a successful exit.

For the emerging company, a holistic solution serving as outside general counsel covering all legal needs from company formation and financing to day-to-day operational demands involving IP, corporate, labor and employment, cyber and data, tax, and when necessary, litigation.

Demonstrated success delivering results; taking investments to profitable results

What differentiates the Honigman team among the emerging company and venture capital industry is our proven results. Among the most active transactional law firms, Honigman is a partner to the company and champion for its success. We embed within the company as a partner delivering a keen understanding of what makes each client unique. And we take that knowledge to devise a growth strategy with a future eye to create a liquidity event…whether a sale to a strategic, a new investor, or take public.

A nationally recognized team investors seek and founders trust

Clients turn to Honigman for its transactional prowess. The firm rivals BigLaw with its volume of financings and transactions, often across the table in negotiations. The team possesses a national reputation advising leading funds, executing on investment strategy and bringing the company’s innovations to market. Combined with a skilled IP team and full complement of legal services, investors trust Honigman to deliver.

A leader in the life sciences and health care industry and deep knowledge in the markets that matter most

We rival, and exceed, the competition in our knowledge and experience in the life sciences industry. The team has decades of proven results in medical device, biotechnology and pharmaceuticals along with the entire drug development ecosystem. Honigman’s IP lawyers have evaluated and maximized assets involving small and large molecules, biosimilars, genomics, peptides and proteins, and more.